Anti-cancer drugs
Comparative efficacy and safety of S-1 plus oxaliplatin with sintilimab vs. paclitaxel-S-1-oxaliplatin and docetaxel-oxaliplatin-5-fluorouracil as first-line therapy for advanced gastric cancer.
Yicong Wang, Bingyang Ma, Chenguang Zhang, Yuwen Wang, Ting Pan, Chunlong Zhao, Baojia Cai, Pengjie Yu, Bin Guo, Jinfu Ma
Published: 202510.1097/CAD.0000000000001782
Abstract
This study compared the efficacy and safety of S-1 + oxaliplatin (SOX) plus sintilimab, albumin-bound paclitaxel + oxaliplatin (P-SOX), and docetaxel + oxaliplatin + 5-fluorouracil (DOF) as neoadjuvant regimens for advanced gastric cancer. We retrosp…
Preview only. Read the full abstract at the source